Document Detail


Gold nanoparticle research before and after the Brust-Schiffrin method.
MedLine Citation:
PMID:  23032158     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In this viewpoint we discuss the early contribution from Brust et al., which is not only the most cited paper ever published in Chem. Commun., but also a landmark in gold nanoparticle research and in nanotechnology. We provide here an overview of its major contributions and how the field has evolved since its publication in 1994.
Authors:
Luis M Liz-Marzán
Related Documents :
10770318 - Tobacco industry efforts subverting international agency for research on cancer's secon...
23986528 - Health research, development and innovation in england from 1988 to 2013: from research...
24357928 - Examining the interface between substance misuse and intimate partner violence.
19023828 - New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
23752908 - Ushering in the study and treatment of preclinical alzheimer disease.
23100608 - Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondyl...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-3
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departamento de Química Física, Universidade de Vigo, 36310 Vigo, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of dark phase restricted high fat feeding on myocardial adaptation in mice.
Next Document:  Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years aft...